Metabolism-based GP-2250 in combination with gemcitabine as a novel approach to pancreatic cancer: A mouse xenograft study- in vitro and in vivo. Journal of Clinical Oncology Vol. 28, No. 15-suppl. May 2020

March 30, 2022 / 0 Minute Read